Virgin Galactic Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Successfully Flew Six Human Spaceflights in Six Months in 2023
-
'Galactic 06'
Mission Completed in
January 2024 - Delta Class Spaceships On Track for Ground and Flight Testing in 2025 and Commercial Service in 2026
Fourth Quarter 2023 Financial Highlights
-
Cash position remains strong, with cash, cash equivalents and marketable securities of
$982 million as ofDecember 31, 2023 . -
Revenue of
$3 million , compared to$1 million in the fourth quarter of 2022, driven by commercial spaceflights and membership fees related to future astronauts. -
GAAP total operating expenses of
$117 million , compared to$154 million in the fourth quarter of 2022. Non-GAAP total operating expenses of$100 million in the fourth quarter of 2023, compared to$140 million in the fourth quarter of 2022. -
Net loss of
$104 million , compared to a$151 million net loss in the fourth quarter of 2022, with the improvement primarily driven by lower operating expenses and an increase in interest income. -
Adjusted EBITDA totaled
$(84) million , compared to$(133) million in the fourth quarter of 2022, primarily driven by lower operating expenses and an increase in interest income. -
Net cash used in operating activities totaled
$95 million , compared to$131 million in the fourth quarter of 2022. -
Cash paid for capital expenditures totaled
$18 million , compared to$4 million in the fourth quarter of 2022. -
Free cash flow totaled
$(114) million , compared to$(135) million in the fourth quarter of 2022.
Full Year 2023 Financial Highlights
-
Revenue of
$7 million , compared to$2 million in 2022, driven by commercial spaceflights and membership fees related to future astronauts. -
Net loss of
$502 million , compared to a$500 million net loss in 2022. -
GAAP total operating expenses of
$538 million , compared to$502 million in 2022. Non-GAAP total operating expenses of$476 million , compared to$445 million in 2022. -
Adjusted EBITDA totaled
$(427) million , compared to$(431) million in 2022. -
Net cash used in operating activities totaled
$448 million , compared to$380 million in 2022. -
Cash paid for capital expenditures totaled
$44 million , compared to$16 million in 2022. -
Free cash flow totaled
$(493) million , compared to$(397) million in 2022. -
Generated
$484 million in gross proceeds through the issuance of 122.8 million shares of common stock as part of the Company's at-the-market offering programs.
Business Updates
- ‘Galactic 07’ spaceflight mission planned for the second quarter of 2024.
-
Spaceship factory in
Arizona on track to open in mid-2024. - Production schedule for the Delta Class spaceships remains on track for revenue service in 2026.
Financial Guidance
The following forward-looking statements reflect our expectations for the first quarter of 2024 as of
-
Revenue for the first quarter of 2024 is expected to be approximately
$2 million . -
Free cash flow for the first quarter of 2024 is expected to be in the range of
$(125) million to$(135) million .
Non-GAAP Financial Measures
In addition to the Company's results prepared in accordance with generally accepted accounting principles in
Conference Call Information
About
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our spaceflight systems, next commercial space mission and proposed timing thereof, scaling of our future fleet, providing repeatable and reliable access to space, development of our
Fourth Quarter 2023 Financial Results
|
||||||||||||||||
Condensed Consolidated Statements of Operations and Comprehensive Loss |
||||||||||||||||
(In thousands, except per share amounts) |
||||||||||||||||
|
|
Three Months Ended |
|
Year Ended |
||||||||||||
|
|
|
|
|
||||||||||||
|
|
2023 |
|
2022 |
|
2023 |
|
2022 |
||||||||
|
|
|
|
|
|
|
|
|
||||||||
Revenue |
|
$ |
2,809 |
|
|
$ |
869 |
|
|
$ |
6,800 |
|
|
$ |
2,312 |
|
|
|
|
|
|
|
|
|
|
||||||||
Operating expenses: |
|
|
|
|
|
|
|
|
||||||||
Spaceline operations |
|
|
24,338 |
|
|
|
1,169 |
|
|
|
50,538 |
|
|
|
1,906 |
|
Research and development |
|
|
53,848 |
|
|
|
102,596 |
|
|
|
295,140 |
|
|
|
314,174 |
|
Selling, general and administrative |
|
|
30,844 |
|
|
|
47,298 |
|
|
|
174,864 |
|
|
|
175,118 |
|
Depreciation and amortization |
|
|
3,646 |
|
|
|
3,117 |
|
|
|
13,369 |
|
|
|
11,098 |
|
Special charges |
|
|
4,398 |
|
|
|
— |
|
|
|
4,398 |
|
|
|
— |
|
Total operating expenses |
|
|
117,074 |
|
|
|
154,180 |
|
|
|
538,309 |
|
|
|
502,296 |
|
|
|
|
|
|
|
|
|
|
||||||||
Operating loss |
|
|
(114,265 |
) |
|
|
(153,311 |
) |
|
|
(531,509 |
) |
|
|
(499,984 |
) |
|
|
|
|
|
|
|
|
|
||||||||
Interest income |
|
|
13,644 |
|
|
|
6,175 |
|
|
|
42,234 |
|
|
|
12,502 |
|
Interest expense |
|
|
(3,224 |
) |
|
|
(3,206 |
) |
|
|
(12,872 |
) |
|
|
(12,130 |
) |
Other income, net |
|
|
99 |
|
|
|
51 |
|
|
|
263 |
|
|
|
58 |
|
Loss before income taxes |
|
|
(103,746 |
) |
|
|
(150,291 |
) |
|
|
(501,884 |
) |
|
|
(499,554 |
) |
Income tax expense |
|
|
238 |
|
|
|
529 |
|
|
|
453 |
|
|
|
598 |
|
Net loss |
|
|
(103,984 |
) |
|
|
(150,820 |
) |
|
|
(502,337 |
) |
|
|
(500,152 |
) |
Other comprehensive income (loss): |
|
|
|
|
|
|
|
|
||||||||
Foreign currency translation adjustment |
|
|
72 |
|
|
|
168 |
|
|
|
81 |
|
|
|
(146 |
) |
Unrealized gain (loss) on marketable securities |
|
|
1,608 |
|
|
|
2,916 |
|
|
|
7,616 |
|
|
|
(5,311 |
) |
Total comprehensive loss |
|
$ |
(102,304 |
) |
|
$ |
(147,736 |
) |
|
$ |
(494,640 |
) |
|
$ |
(505,609 |
) |
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
Net loss per share: |
|
|
|
|
|
|
|
|
||||||||
Basic and diluted |
|
$ |
(0.26 |
) |
|
$ |
(0.55 |
) |
|
$ |
(1.49 |
) |
|
$ |
(1.89 |
) |
|
|
|
|
|
|
|
|
|
||||||||
Weighted-average shares outstanding: |
|
|
|
|
|
|
|
|
||||||||
Basic and diluted |
|
|
399,766 |
|
|
|
274,902 |
|
|
|
337,262 |
|
|
|
263,947 |
|
|
||||||||
Condensed Consolidated Balance Sheets |
||||||||
(In thousands) |
||||||||
|
|
|
||||||
|
|
|
||||||
|
|
2023 |
|
2022 |
||||
Assets |
|
|
|
|
||||
Current assets: |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
216,799 |
|
|
$ |
302,291 |
|
Restricted cash |
|
|
36,793 |
|
|
|
40,336 |
|
Marketable securities, short-term |
|
|
657,238 |
|
|
|
606,716 |
|
Inventories |
|
|
16,301 |
|
|
|
24,043 |
|
Prepaid expenses and other current assets |
|
|
23,698 |
|
|
|
28,228 |
|
Total current assets |
|
|
950,829 |
|
|
|
1,001,614 |
|
Marketable securities, long-term |
|
|
71,596 |
|
|
|
30,392 |
|
Property, plant and equipment, net |
|
|
93,806 |
|
|
|
53,658 |
|
Other non-current assets |
|
|
63,286 |
|
|
|
54,274 |
|
Total assets |
|
$ |
1,179,517 |
|
|
$ |
1,139,938 |
|
Liabilities and Stockholders' Equity |
|
|
|
|
||||
Current liabilities: |
|
|
|
|
||||
Accounts payable |
|
$ |
32,415 |
|
|
$ |
16,326 |
|
Accrued liabilities |
|
|
50,863 |
|
|
|
61,848 |
|
Customer deposits |
|
|
97,841 |
|
|
|
102,647 |
|
Other current liabilities |
|
|
4,541 |
|
|
|
3,232 |
|
Total current liabilities |
|
|
185,660 |
|
|
|
184,053 |
|
Non-current liabilities: |
|
|
|
|
||||
Convertible senior notes, net |
|
|
417,886 |
|
|
|
415,720 |
|
Other long-term liabilities |
|
|
70,495 |
|
|
|
59,942 |
|
Total liabilities |
|
|
674,041 |
|
|
|
659,715 |
|
Stockholders' Equity |
|
|
|
|
||||
Common stock |
|
|
40 |
|
|
|
28 |
|
Additional paid-in capital |
|
|
2,631,197 |
|
|
|
2,111,316 |
|
Accumulated deficit |
|
|
(2,126,132 |
) |
|
|
(1,623,795 |
) |
Accumulated other comprehensive income (loss) |
|
|
371 |
|
|
|
(7,326 |
) |
Total stockholders' equity |
|
|
505,476 |
|
|
|
480,223 |
|
Total liabilities and stockholders' equity |
|
$ |
1,179,517 |
|
|
$ |
1,139,938 |
|
|
||||||||||||||||
Condensed Consolidated Statements of Cash Flows |
||||||||||||||||
(In thousands) |
||||||||||||||||
|
|
Three Months Ended |
|
Year Ended |
||||||||||||
|
|
|
|
|
||||||||||||
|
|
2023 |
|
2022 |
|
2023 |
|
2022 |
||||||||
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
||||||||
Net loss |
|
$ |
(103,984 |
) |
|
$ |
(150,820 |
) |
|
$ |
(502,337 |
) |
|
$ |
(500,152 |
) |
Stock-based compensation |
|
|
8,660 |
|
|
|
11,221 |
|
|
|
44,258 |
|
|
|
45,709 |
|
Depreciation and amortization |
|
|
3,646 |
|
|
|
3,117 |
|
|
|
13,369 |
|
|
|
11,098 |
|
Amortization of debt issuance costs |
|
|
548 |
|
|
|
532 |
|
|
|
2,166 |
|
|
|
1,998 |
|
Other non-cash items |
|
|
(7,076 |
) |
|
|
544 |
|
|
|
(13,576 |
) |
|
|
10,800 |
|
Change in operating assets and liabilities: |
|
|
|
|
|
|
|
|
||||||||
Inventories |
|
|
761 |
|
|
|
(1,192 |
) |
|
|
4,757 |
|
|
|
5,625 |
|
Other current and non-current assets |
|
|
1,501 |
|
|
|
(5,063 |
) |
|
|
11,798 |
|
|
|
(2,810 |
) |
Accounts payable and accrued liabilities |
|
|
581 |
|
|
|
11,323 |
|
|
|
(2,360 |
) |
|
|
35,151 |
|
Customer deposits |
|
|
(82 |
) |
|
|
(1,324 |
) |
|
|
(4,806 |
) |
|
|
11,784 |
|
Other current and long-term liabilities |
|
|
136 |
|
|
|
420 |
|
|
|
(1,462 |
) |
|
|
556 |
|
Net cash used in operating activities |
|
|
(95,309 |
) |
|
|
(131,242 |
) |
|
|
(448,193 |
) |
|
|
(380,241 |
) |
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
||||||||
Capital expenditures |
|
|
(18,368 |
) |
|
|
(4,183 |
) |
|
|
(44,309 |
) |
|
|
(16,489 |
) |
Purchases of marketable securities |
|
|
(136,886 |
) |
|
|
(99,620 |
) |
|
|
(1,009,836 |
) |
|
|
(704,565 |
) |
Proceeds from maturities and calls of marketable securities |
|
|
235,526 |
|
|
|
140,277 |
|
|
|
937,872 |
|
|
|
434,889 |
|
Net cash provided by (used in) investing activities |
|
|
80,272 |
|
|
|
36,474 |
|
|
|
(116,273 |
) |
|
|
(286,165 |
) |
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
||||||||
Payments of finance lease obligations |
|
|
(60 |
) |
|
|
(102 |
) |
|
|
(235 |
) |
|
|
(234 |
) |
Proceeds from convertible senior notes |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
425,000 |
|
Debt issuance costs |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(11,278 |
) |
Purchase of capped call |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(52,318 |
) |
Repayment of commercial loan |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(310 |
) |
Proceeds from issuance of common stock |
|
|
— |
|
|
|
3,753 |
|
|
|
484,145 |
|
|
|
103,326 |
|
Proceeds from issuance of common stock pursuant to stock options exercised |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
49 |
|
Withholding taxes paid on behalf of employees on net settled stock-based awards |
|
|
(239 |
) |
|
|
(505 |
) |
|
|
(3,240 |
) |
|
|
(3,984 |
) |
Transaction costs related to issuance of common stock |
|
|
(133 |
) |
|
|
(111 |
) |
|
|
(5,239 |
) |
|
|
(1,248 |
) |
Net cash provided by (used in) financing activities |
|
|
(432 |
) |
|
|
3,035 |
|
|
|
475,431 |
|
|
|
459,003 |
|
Net decrease in cash, cash equivalents and restricted cash |
|
|
(15,469 |
) |
|
|
(91,733 |
) |
|
|
(89,035 |
) |
|
|
(207,403 |
) |
Cash, cash equivalents and restricted cash at beginning of period |
|
|
269,061 |
|
|
|
434,360 |
|
|
|
342,627 |
|
|
|
550,030 |
|
Cash, cash equivalents and restricted cash at end of period |
|
$ |
253,592 |
|
|
$ |
342,627 |
|
|
$ |
253,592 |
|
|
$ |
342,627 |
|
|
|
|
|
|
|
|
|
|
||||||||
Cash and cash equivalents |
|
$ |
216,799 |
|
|
$ |
302,291 |
|
|
$ |
216,799 |
|
|
$ |
302,291 |
|
Restricted cash |
|
|
36,793 |
|
|
|
40,336 |
|
|
|
36,793 |
|
|
|
40,336 |
|
Cash, cash equivalents and restricted cash |
|
$ |
253,592 |
|
|
$ |
342,627 |
|
|
$ |
253,592 |
|
|
$ |
342,627 |
|
USE OF NON-GAAP FINANCIAL MEASURES
This press release references certain financial measures that are not prepared in accordance with generally accepted accounting principles in
The Company believes that presenting these non-GAAP financial measures provides useful supplemental information to investors about the Company in understanding and evaluating its operating results, enhancing the overall understanding of its past performance and future prospects, and allowing for greater transparency with respect to key financial metrics used by its management in financial and operational-decision making. However, there are a number of limitations related to the use of non-GAAP measures and their nearest GAAP equivalents. For example, other companies may calculate non-GAAP measures differently, or may use other measures to calculate their financial performance, and therefore any non-GAAP measures the Company uses may not be directly comparable to similarly titled measures of other companies.
A reconciliation of total operating expenses to total non-GAAP operating expenses for the three months ended
|
|
Three Months Ended |
|
Year Ended |
||||||||
|
|
|
|
|
||||||||
|
|
2023 |
|
2022 |
|
2023 |
|
2022 |
||||
Total operating expenses |
|
$ |
117,074 |
|
$ |
154,180 |
|
$ |
538,309 |
|
$ |
502,296 |
Stock-based compensation |
|
|
8,660 |
|
|
11,221 |
|
|
44,258 |
|
|
45,709 |
Depreciation and amortization |
|
|
3,646 |
|
|
3,117 |
|
|
13,369 |
|
|
11,098 |
Special charges(1) |
|
|
4,398 |
|
|
— |
|
|
4,398 |
|
|
— |
Total non-GAAP operating expenses |
|
$ |
100,370 |
|
$ |
139,842 |
|
$ |
476,284 |
|
$ |
445,489 |
(1) Special charges includes severance and related benefit costs in connection with the Company's workforce reduction. |
A reconciliation of net loss to Adjusted EBITDA for the three months ended
|
|
Three Months Ended |
|
Year Ended |
||||||||||||
|
|
|
|
|
||||||||||||
|
|
2023 |
|
2022 |
|
2023 |
|
2022 |
||||||||
Net loss |
|
$ |
(103,984 |
) |
|
$ |
(150,820 |
) |
|
$ |
(502,337 |
) |
|
$ |
(500,152 |
) |
Interest expense |
|
|
3,224 |
|
|
|
3,206 |
|
|
|
12,872 |
|
|
|
12,130 |
|
Income tax expense |
|
|
238 |
|
|
|
529 |
|
|
|
453 |
|
|
|
598 |
|
Depreciation and amortization |
|
|
3,646 |
|
|
|
3,117 |
|
|
|
13,369 |
|
|
|
11,098 |
|
Stock-based compensation |
|
|
8,660 |
|
|
|
11,221 |
|
|
|
44,258 |
|
|
|
45,709 |
|
Special charges(1) |
|
|
4,398 |
|
|
|
— |
|
|
|
4,398 |
|
|
|
— |
|
Adjusted EBITDA |
|
$ |
(83,818 |
) |
|
$ |
(132,747 |
) |
|
$ |
(426,987 |
) |
|
$ |
(430,617 |
) |
(1) Special charges includes severance and related benefit costs in connection with the Company's workforce reduction. |
The following table reconciles net cash used in operating activities to free cash flow for the three months ended
|
|
Three Months Ended |
|
Year Ended |
||||||||||||
|
|
2023 |
|
2022 |
|
2023 |
|
2022 |
||||||||
Net cash used in operating activities |
|
$ |
(95,309 |
) |
|
$ |
(131,242 |
) |
|
$ |
(448,193 |
) |
|
$ |
(380,241 |
) |
Capital expenditures |
|
|
(18,368 |
) |
|
|
(4,183 |
) |
|
|
(44,309 |
) |
|
|
(16,489 |
) |
Free cash flow |
|
$ |
(113,677 |
) |
|
$ |
(135,425 |
) |
|
$ |
(492,502 |
) |
|
$ |
(396,730 |
) |
The following table reconciles forecasted net cash used in operating activities to forecasted free cash flow for the three months ended
|
|
|
|
|
|
Net cash used in operating activities |
|
|
Capital expenditures |
|
(40,000)-(45,000) |
Free cash flow |
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20240227947977/en/
For media inquiries:
Aleanna Crane - Vice President, Communications
news@virgingalactic.com
575.800.4422
For investor inquiries:
vg-ir@virgingalactic.com
949.774.7637
Source: